KRAS c.556G>A ;(p.V186I)

Variant ID: 12-25362740-C-T

NM_004985.3(KRAS):c.556G>A;(p.V186I)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo.

Blood Advances
Zhang, Xiaoshan X; Zhang, Ran R; Ren, Chenghui C; Xu, Yi Y; Wu, Shuhong S; Meng, Carrie C; Pataer, Apar A; Song, Xingzhi X; Zhang, Jianhua J; Yao, Yixin Y; He, Hua H; Chen, Huiqin H; Ma, Wencai W; Wang, Jing J; Meric-Bernstam, Funda F; Champlin, Richard E RE; Heymach, John V JV; Rooney, Cliona M CM; Swisher, Stephen G SG; Vaporciyan, Ara A AA; Roth, Jack A JA; You, M James MJ; Wang, Michael M; Fang, Bingliang B
Publication Date: 2022-02-08

Variant appearance in text: KRAS: V186I
PubMed Link: 34861697
Variant Present in the following documents:
  • advancesADV2021006156-suppl2.xlsx, sheet 2
View BVdb publication page



Blood-based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Pancreatic Cancer and its Value to Guide Clinical Treatment.

Journal Of Cancer
Li, Hengchao H; Di, Yang Y; Li, Ji J; Jiang, Yongjian Y; He, Hang H; Yao, Lie L; Gu, Jichun J; Lu, Jiajun J; Song, Jia J; Chen, Shiqing S; Cai, Shangli S; Jin, Chen C; Yuan, Zhou Z; Fu, Deliang D
Publication Date: 2020

Variant appearance in text: KRAS: V186I
PubMed Link: 32489450
Variant Present in the following documents:
  • Main text
  • jcav11p4316.pdf
View BVdb publication page